[Clinical characteristics and therapeutic insights of pediatric allergic fungal rhinosinusitis].

PubMed 2026 Open access

Read full text
Authors: Chunmiao Li, Ying Li, Yanxia Xu, Yanyan Wei, Hong Zhang, Fangyu Cai, Qingchuan Duan, Dongjie Seng
DOI: 10.13201/j.issn.2096-7993.2026.02.013
Cited by: 0

Abstract

ESS is the primary therapeutic modality for AFRS, emphasizing complete removal of allergic mucin and diseased tissue while preserving critical anatomical structures. Image-guided navigation significantly enhances surgical accuracy and safety. Perioperative adjunctive therapy, including corticosteroids, antihistamines, leukotriene receptor antagonists, and nasal irrigation, effectively reduces inflammation. Routine postoperative monitoring further decreases recurrence rates.

Fields of Study & Subjects

Sinusitis and nasal conditions Nasal Surgery and Airway Studies Antifungal resistance and susceptibility

Publication details

Journal / source
PubMed
Volume
40
Issue
2
Pages
182–187
Publication date
1 February 2026
Language
ZH